Package 72205-087-30
Brand: tiagabine hydrochloride
Generic: tiagabine hydrochloridePackage Facts
Identity
Package NDC
72205-087-30
Digits Only
7220508730
Product NDC
72205-087
Description
30 TABLET in 1 BOTTLE (72205-087-30)
Marketing
Marketing Status
Brand
tiagabine hydrochloride
Generic
tiagabine hydrochloride
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7c034fe0-cdac-49e1-8e39-592846ea3bec", "openfda": {"upc": ["0372205086302", "0372205087309", "0372205085305", "0372205084308"], "unii": ["DQH6T6D8OY"], "rxcui": ["1299903", "1299909", "1299911", "1299917"], "spl_set_id": ["7c034fe0-cdac-49e1-8e39-592846ea3bec"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (72205-087-30)", "package_ndc": "72205-087-30", "marketing_start_date": "20211123"}], "brand_name": "Tiagabine Hydrochloride", "product_id": "72205-087_7c034fe0-cdac-49e1-8e39-592846ea3bec", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72205-087", "generic_name": "Tiagabine Hydrochloride", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tiagabine Hydrochloride", "active_ingredients": [{"name": "TIAGABINE HYDROCHLORIDE", "strength": "16 mg/1"}], "application_number": "ANDA214816", "marketing_category": "ANDA", "marketing_start_date": "20211123", "listing_expiration_date": "20261231"}